Mental, Behavioral and Development Health

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the April 2024 issue of Contemporary Pediatrics.

Investigators sought to evaluate characteristics of adolescents with a history of depression who do not endorse risk via the PHQ item 9, which is commonly used to screen for self-harm and suicide risk.

Data from a recent study revealed that stigma associated with chronic skin diseases made an impact on the quality of life of affected children and adolescents.

A discussion based on an FDA-cleared objective ADHD diagnostic test developed by Qbtech.

Though concern exists about the associations of marijuana legalization and youth use, no links were found in a recent study.

Research in AJOG: Maternal hyperoxygenation doesn't boost neonatal Apgar scores in pathologic fetal heart rate tracing, showing no FiO2 benefit.

Perry Roy, MD, explains how an FDA-cleared objective test can assist in an ADHD diagnosis.

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the April 2024 issue of Contemporary Pediatrics.

An assessment into development scores before, during and after the COVID-19 pandemic show children aged 0 - 5 years old may only had been minimally impacted in communication and problem-solving skills.

Medicaid registry data show parents and guardians whose children have been referred to CPS are more than 3-fold likely to have a substance use disorder.

A new study explored increased health care utilization of children among several specific sleep disorders, race, and age.

NeuroStar Advanced Therapy becomes the first and only transcranial magnetic stimulation therapy cleared by the FDA as an adjunct treatment for patients 15 years and up with depression.

Cynthia Chew, DNP, CPNP-PC, IBCLC, assistant professor, University of Pittsburgh, breaks down her session, "The Why and How of Screening for Perinatal Mental Health Disorders in Pediatric Primary Care," presented at NAPNAP 2024.

"We cannot lead, innovate, and learn if we do not listen to those we seek to serve. Listening is the foundation of trust and trust is the foundation of every therapeutic alliance."

Experts highlight the importance of mental health screening at well-child visits.

Psychopharmacologic agents used in the pediatric population from the perspective of their interactions with receptor targets in the brain and body.

Access to mental health care for youth living in rural areas presents several challenges. Jennifer Marr, DNP, APRN, CNP, PNP-C, explains how a mobile mental health clinic could expand care.

The Tennessee STAT tool was associated with improved primary care provider perspective and confidence to lead, rather than refer, on pediatric autism diagnosis.

In 2021, pediatric mental health conditions were associated with $31 billion in child spending and $59 billion in household spending, which made up 46.6% of all pediatric medical spending that year.

Research has demonstrated that SGDY exhibit significantly elevated incidence of mental health diagnoses and conditions compared with their counterparts, including higher rates of suicidality, depressive and anxiety disorders, and substance misuse.

In the study period and among individuals aged 12 to 24 years, mental health-associated visits increased nearly 2-fold from 2006 to 2019.

Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, believes behavioral health is currently at the forefront of pediatric health care and explains how simple questions can lead to better care for a child.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights our March Mental Health issue of Contemporary Pediatrics.

"Collaboration can help us make more accurate diagnoses, develop more effective multimodal treatment plans, and monitor progress in many areas," said James Wallace, MD.

A new study found female teens and young adults were more likely to have an increased antidepressant dispensing rate during the pandemic than male peers.